subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "522"
part_subject: "IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "522.1920"
section_subject: "Prochlorperazine and isopropamide."
cfr_reference: "21 CFR 522.1920"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. Each milliliter of solution contains prochlorperazine edisylate equivalent to 4 milligrams (mg) prochlorperazine and isopropamide iodide equivalent to 0.28 mg of isopropamide.
(b)Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c)Conditions of use—(1) Amount. (i) Dosage is administered by subcutaneous injection twice daily as follows:
(ii)Following the last injection, administer prochlorperazine and isopropamide sustained release capsules as indicated.
(2)Indications for use. For use in dogs and cats in which gastrointestinal disturbances are associated with emotional stress.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.